ResearchNet - RechercheNet

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Performance Measurement
• Review Process and Evaluation
• How to Apply
• Contact Information
• Sponsor Description
• Additional Information

Description

Priority Announcements offer additional sources of funding for highly rated applications that are relevant to specific research priority areas. Applications are submitted through the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.

• Aboriginal Ways of Knowing and Two-Eyed Seeing (Bridge Funding)
• Breast Cancer (Bridge Funding)
• Circulatory and Respiratory Health – New Investigators (Bridge Funding)
• First Nations, Inuit and/or Métis Health (Bridge Funding)
• Genetics: Research Priorities (Bridge Funding)
• HIV/AIDS
• INMD Start-up Funds (Bridge funding for Clinicians and New Investigators)
• Musculoskeletal, Skin and Oral Health: New Investigators (Bridge Funding)
• Neurosciences, Mental Health and Addiction (Bridge Funding)
• Reproductive and Child Health Start-up Grants (Bridge funding)
• Transfusion Science

Objectives

The specific objective of the Operating Grant Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas.

The objective of a Bridge Grant is to provide short-term, partial funding for highly ranked, non-funded applicants in the Open Operating Grant Program to start and/or maintain project/research momentum and to advance research in some way.

Aboriginal Ways of Knowing and Two-Eyed Seeing (Bridge Funding) (AWT)

Summary

• The CIHR Institute of Aboriginal Peoples’ Health (IAPH) will provide funding for applications that are relevant to Aboriginal Knowledge and Ways of Knowing and the “Two-eyed Seeing” Model of Aboriginal Health as they relate to  health, wellness and/or resilience.

Aboriginal Knowledge and Ways of Knowing

• IAPH broadly views Aboriginal Knowledge and Ways of Knowing as complex and contextual. It includes knowledge of and experience with healing practices both ceremonial and physical, such as herbal treatments. Some practices are known externally, while others are closely held within a small circle of knowledge holders.
• Aboriginal Knowledge and Ways of Knowing include the concepts of health, wholeness and resilience, and approaches to wellness and healing. For example, the attainment and maintenance of wellness, including mental, emotional and spiritual health, is often based on Aboriginal teachings and ceremony, which provide a basis for positive self-image and healthy identity. Aboriginal herbal treatments, including the ceremony of their application, are valued in dealing with many chronic conditions including diabetes and arthritis. Indigenous knowledge of the land and its ecology helps sustain health for many First Nations, Inuit and Métis peoples.

“Two-eyed Seeing” Model of Aboriginal Health

• IAPH will provide funding for applications that are relevant to the application of the concept of “two-eyed seeing”, as put forward by Mi’kmaq Elder Albert Marshall. The Institute is interested in funding projects using the two-eyed seeing approach in any area relevant to its mandate.
• Two-eyed seeing recognizes the benefits of seeing from one eye with the strengths of Indigenous ways of knowing, and to see from the other eye with the strengths of Western ways of knowing, and finally to use both of these eyes together. Projects that have a two-eyed seeing approach will be considered eligible under this Priority Announcement.
• More information on the research priorities of CIHR-IAPH can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000.  This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant is $100,000 per annum for one (1) year.

Specific Requirements

• Applicants must select this Priority Announcement from the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• Within the Relevance Form the applicant(s) - i.e., research team - must demonstrate:
  • a close working relationship with the First Nations, Métis or Inuit community/ies or organization(s) involved in the research project; and
  • how their lived Aboriginal experience will enhance their approach to research.*

  * Please note that Aboriginal identity (i.e., being First Nations, Inuit or Métis) is not a sufficient response to the above. Lived aboriginal experience could be demonstrated by individuals that have close relationships and experience with Aboriginal people such as living an extended period of time (e.g., 5 years or more) on a reserve or Northern Inuit community, or through indigenous lived experience with people other than First Nations, Inuit or Métis – e.g., Pacific Islanders, or South American indigenous peoples.

• The grant must be held in Canada.
• Successful applicants may be required to budget funds to attend and actively participate in IAPH activities, such as a yearly research meeting to advance Aboriginal health research.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Breast Cancer (Bridge Funding) (COP)

Summary

• The CIHR Breast Cancer Initiative (BCI) will provide funding for applications that are determined to be relevant to the research priorities below:
  • Mechanisms of breast cancer development
  • Molecular detection and prediction of breast cancer
  • Personalized medicine and breast cancer
  • Breast cancer progression and dissemination
  • Psychosocial, survivorship and health services aspects of breast cancer care
  • Transferring breast cancer knowledge into practice
• More information on the research priorities of CIHR-BCI can be found on the web site of the National Breast Cancer Research Framework.

Funds Available

• The total amount available for this Priority Announcement is $300,000. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant is $100,000 per annum for up to (1) year.

Specific Requirements

• Applicants must select this Priority Announcement from the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• In order to be deemed relevant to this Priority Announcement, projects must include breast cancer as essential elements of the research objectives, hypothesis and analyses and this must be clearly described in the relevance form and project summary.
• Applications may consider other types of cancer but must demonstrate at least 50% relevance to breast cancer.
• The grant must be held in Canada.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Circulatory and Respiratory Health – New Investigators (Bridge Funding) (OCN)

Summary

• The CIHR Institute of Circulatory and Respiratory Health (ICRH) New Investigators Bridge Funding Priority Announcement is designed to fund highly ranked operating grant applications relevant to CIHR-ICRH’s mandate. More information on the research priorities of CIHR-ICRH can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000.
• The maximum amount awarded for a single grant is $100,000 per annum for up to one (1) year.

Specific Requirements

• Applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• The Nominated Principal Applicant must be a New Investigator, and this must be indicated on the relevance form (provide date of first academic appointment). A  New Investigator is defined as a researcher who has completed all formal training but has 5 years or less experience as an independent investigator. One does not need a New Investigator salary award to be classified as a new investigator.
• Under the New Investigator category, the ICRH Bridge Funding Priority Announcement must be the first CIHR operating grant held by the Nominated Principal Applicant.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

First Nations, Inuit and/or Métis Health (Bridge Funding) (IPH)

Summary

• The CIHR Institute of Aboriginal Peoples’ Health (IAPH) will provide funding for applications that are determined to be relevant to its mandate.
• The objective of the CIHR-IAPH bridge funding operating grants is to foster the advancement of a national health research agenda to improve and promote the health of First Nations, Inuit and Métis peoples in Canada.
• More information on the research priorities of CIHR-IAPH can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000.  This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant is $100,000 per annum for one (1) year.

Specific Requirements

• When applying, applicants must select this Priority Announcement from the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• Within the Relevance Form the applicant(s) - i.e., research team - must demonstrate:
  • a close working relationship with the First Nations, Métis or Inuit community/ies or organization(s) involved in the research project; and
  • how their lived Aboriginal experience will enhance their approach to research.*

  * Please note that Aboriginal identity (i.e., being First Nations, Inuit or Métis) is not a sufficient response to the above. Lived aboriginal experience could be demonstrated by individuals that have close relationships and experience with Aboriginal people such as living an extended period of time (e.g., 5 years or more) on a reserve or Northern Inuit community, or through indigenous lived experience with people other than First Nations, Inuit or Métis – e.g., Pacific Islanders, or South American indigenous peoples.

• Successful applicants may be required to budget funds to attend and actively participate in IAPH activities, such as a yearly research meeting to advance Aboriginal health research.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Genetics: Research Priorities (Bridge Funding) (OGB)

Summary

• The CIHR Institute of Genetics (CIHR-IG) will provide funding to applications that are relevant to the following research areas:
  • Computational and Systems Biology
  • From Models and Mechanisms to Therapies
  • Health Services, Policy & Ethical, Legal and Social Issues Research
• More information on the research priorities of CIHR-IG can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant is $100,000 per annum for up to one (1) year.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• Applicants must clearly indicate in the Relevance Form which of the three (3) research priority areas listed above they are applying to.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

HIV/AIDS (HOP/HHP/HBF)

Summary

• The CIHR HIV/AIDS Research Initiative in partnership with the CIHR Institute of Infection and Immunity (CIHR-III) will provide funding for applications that have a primary research focus on HIV/AIDS. The CIHR HIV/AIDS Research Initiative is managed by the Institute of Infection and Immunity and is responsible for implementing the research components of the Federal Initiative to Address HIV/AIDS in Canada and the Canadian HIV Vaccine Initiative (CHVI).
• Research that focuses on key populations identified by the Federal Initiative to Address HIV/AIDS in Canada is highly encouraged. Key populations include: Aboriginal Peoples; gay, bisexual, two-spirit and other men who have sex with men; women; youth at-risk; people who use drugs; people in prison; people living with HIV/AIDS; and people from countries where HIV is endemic. Please visit the Federal Initiative website for information on the key populations and the population specific status reports  which provide guidance on future policy, program and research priorities.
• Information on the research priorities of the CIHR HIV/AIDS Research Initiative can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $3,200,000.
• Of the total funds available, $2,700,000 will support three-year grants. The maximum amount awarded for a single grant is $150,000 per annum for up to three (3) years:
  • $1,800,000 is available to fund applications relevant to Biomedical/Clinical Research;
  • $900,000 is available to fund applications relevant to Health Services/Population Health Research.
• In addition, $500,000 is currently available to support bridge grants relevant to Biomedical/Clinical Research. $100,000 of which is provided by CIHR-III and $400,000 provided by the CIHR HIV/AIDS Research Initiative. The maximum amount awarded for a single bridge grant is $100,000 per annum for up to one(1) year.

Specific Requirements

• Applicants may only apply to one (1) of the two (2) Research Areas in this Priority Announcement. When applying, applicants must select this Priority Announcement and identify which of the two Research Areas is more relevant to their proposal in the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• In order to be deemed relevant to this Priority Announcement, projects must include HIV/AIDS issues as essential elements of the research objectives, hypothesis and analyses and this must be well described in the relevance form and project summary. With respect to diseases or conditions common in people living with HIV/AIDS, the focus of the project must be on the disease/condition within the context of HIV/AIDS. Similarly, in projects investigating determinants of health or health systems that influence a wide range of health issues, HIV/AIDS must be the focus of the investigation.
• All applications determined to be relevant to the Biomedical/Clinical Research Area will be eligible for Bridge Funding.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

INMD Start-up Funds (Bridge funding for Clinicians and New Investigators) (INM)

Summary

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide bridge funding to Clinicians and New Investigators working in the mandate of CIHR-INMD.
  • Clinician Scientists: At the time of application, a candidate must hold a professional degree and have completed at least two (2) years of post-graduate clinical training.
  • New Investigators: Investigators with less than six (6) years of experience as independent investigators since their first academic appointment.
• More information on the research priorities of CIHR-INMD can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant is $100,000 per annum for up to one (1) year.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• Research proposals must fall within CIHR-INMD's mandate.
• This Priority Announcement will require the completion of a Relevance Form.
• The Nominated Principal Applicant must be a Clinician Scientist and/or a New Investigator, and this must be indicated on the relevance form (provide date of first academic appointment for New Investigator). A  New Investigator is defined as a researcher who has completed all formal training but has six (6) years or less experience as an independent investigator. One does not need a New Investigator salary award to be classified as a new investigator.
• Nominated Principal Investigators are eligible to receive only one (1) grant at a time through CIHR-INMD's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from CIHR-INMD's Priority Announcement program, are not eligible for funding from this Priority Announcement.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Musculoskeletal, Skin and Oral Health: New Investigators (Bridge Funding) (ONM/ONS/ONO)

Summary

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications from New Investigators that are determined to be relevant to the mandate of IMHA.
• More information on the research priorities of CIHR-IMHA can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $1,000,000. This amount may increase if additional funding partners decide to participate.
• The maximum amount awarded for a single grant is $100,000 for up to one year.
• Of this $1,000,000:
  • $400,000 is available to fund applications relevant to Musculoskeletal Health (arthritis, musculoskeletal rehabilitation, bone, skeletal muscle);
  • $300,000 is available to fund applications relevant to Skin Health;
  • $300,000 is available to fund applications relevant to Oral Health.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• Applicants may only apply to one of the three(3) Research Areas in this Priority Announcement.
• This Priority Announcement will require the completion of a Relevance Form.
• The Nominated Principal Applicant must be a New Investigator, and this must be indicated on the relevance form (provide date of first academic appointment). A New Investigator is defined as a researcher who has completed all formal training but has 5 years or less experience as an independent investigator. One does not need a New Investigator salary award to be classified as a new investigator.
• Nominated Principal Investigators are eligible to receive only one grant at a time through IMHA's priority announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from IMHA's priority announcement program, are not eligible for funding from this priority announcement.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Neurosciences, Mental Health and Addiction (Bridge Funding) (INO)

Summary

• The CIHR Institute of Neurosciences, Mental Health and Addiction (INMHA) will provide funding for applications that are relevant to:
  • Brain health
• More information on the research priorities of CIHR-INMHA can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000.
• The maximum amount awarded for a single grant is $100,000 per annum for up to one year.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• This Priority Announcement will not require the completion of a Relevance Form.
• Research proposals must fall within CIHR-INMHA's mandate.
• Nominated Principal Investigators are eligible to receive only one (1) grant at a time through CIHR-INMHA's Priority Announcement program. Researchers who hold a CIHR open operating grant as a Nominated Principal Investigator, as of the anticipated start date for funding from CIHR-INMHA's Priority Announcement program, are not eligible for funding from this Priority Announcement.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Reproductive and Child Health Start-up Grants (Bridge funding) (IHD)

Summary

• The CIHR Institute of Human Development, Child and Youth Health (IHDCYH) will provide funding for applications from New Investigators that are relevant to the research priorities below:
  • Healthy Developmental Trajectories;
    • Developmental Origins of Health and Disease through the Lifespan
    • Preterm Birth
  • Healthy Reproduction, Pregnancy, Childhood and Youth; and
    • Environmental Health
    • Healthy Pregnancy
  • Healthy Public Policy and Systems Integration to ensure the best outcomes for families, infants, children and youth
    • Integrated Child and Youth Research and Health Services
    • Mental Health
• The objective of this priority announcement is to further strengthen research that relates to the research priorities areas of the CIHR-IHDCYH by increasing research capacity.
• More information on the research priorities of CIHR-IHDCYH can be found on its website.

Funds Available

• The total amount available for this Priority Announcement is $300,000.
• The maximum amount awarded for a single grant is $100,000 per annum for up to one year.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• The Nominated Principal Applicant must be a New Investigator, and this must be indicated on the relevance form (provide date of first academic appointment). A New Investigator is defined as a researcher who has completed all formal training but has 5 years or less experience as an independent investigator. One does not need a New Investigator salary award to be classified as a new investigator.
• Grants are offered only to investigators who have never held a CIHR grant as a Nominated Principal Investigator (including the Sick Kids Foundation (SKF)/IHDCYH New Investigators Grants Program but excluding recipients of Planning and dissemination grants).
• The grant must be held in Canada.
• This Priority Announcement requires the submission of an electronic Final Report to CIHR.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Transfusion Science (OTS)

Summary

• The CIHR Institute of Circulatory and Respiratory Health (ICRH) in partnership with Canadian Blood Services (CBS) will provide funding for applications that are  relevant to the following research priority areas described below:
  • Blood Supply Risk: Examples of relevant areas include research on blood donor deferral strategies and the risk of transmission of blood borne diseases; policy development and social aspects of blood system safety and risk tolerance; and emerging pathogens in specific populations including sexually active gay men.
  • Blood Utilization and Conservation: Blood products and their derivatives include cellular blood components (red blood cells and platelets), plasma products, therapeutic proteins fractioned from plasma, and replacement products for any of these including both recombinant proteins and synthetic materials. Conservation refers to strategies to reduce the use of donor-derived blood products.
  • Transfusion Related Acute Lung Injury (TRALI): Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animal models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy  making, identification of factors (including genetic factors) that increase a recipient’s susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI. Animal models must recapitulate known clinical aspects of human TRALI disease to be considered relevant.
• More information on the research priorities of CIHR-ICRH and CBS can be found on their websites.

Funds Available

• The total amount available for this Priority Announcement is $1,350,000. This amount may increase if additional funding partners or internal collaborators decide to participate.
• The maximum amount awarded for a single grant will be as recommended by peer review, including CIHR administrative cuts, for up to three (3) years.
• Funding will be provided by the Canadian Blood Services.

Specific Requirements

• When applying, applicants must select this Priority Announcement in the drop-down menu in ResearchNet.
• This Priority Announcement will require the completion of a Relevance Form.
• Applicants must clearly indicate in the Relevance Form which of the three research priority areas listed above they are applying to.
• Randomized Controlled Trials (RCTs) over the maximum in both grant value and term available will not be eligible for this competition.
• Only those applications judged to be in the top half of the grants reviewed by their respective committee (i.e., Committee Ranking Percent of 50% or above) will be eligible for funding.
• The grant must be held in Canada.

Contact Information

• For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information".
• For questions about this research initiative and research objectives, see the "Additional Information".

Eligibility

For Eligibility, please refer to the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Guidelines

For Guidelines, please refer to the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Performance Measurement

For Performance Measurement, please refer to the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Review Process and Evaluation

Relevance Review Process

CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described in each particular Priority Announcement description.

Applications that are not deemed to be relevant will be withdrawn from the Priority Announcement competition, but will continue to be considered for funding through the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Peer Review

Peer review committees will not be informed of applications submitted for funding through this announcement.

For Peer Review and Evaluation Criteria please refer to the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity.

Funding Decision

Upon completion of peer review, CIHR will generate a ranking list, ratings and recommendations. The list will be used for funding decision-making purposes.

Within each Priority Announcement competition, applications will be funded from the top down in order of ranking as far as budgets will allow.

Applications that receive a rating below 3.5 will not be funded.

How to Apply

Important: Please read all instructions to familiarize yourself with the application process before applying. For new applicants or for those wanting a reminder of the main application procedures, an overview of CIHR's application processes can be found under Apply for Funding. Note that these are general instructions only as the specific application instructions for this funding opportunity are located below.

• The application process for this funding opportunity is comprised of one(1) phase: Application.
• Applications are submitted through the "201503MOP" competition of the Operating Grant: Transitional Operating Grant: 2014-2015 funding opportunity. While you must complete the "Registration" phase of the Operating Grant: Transitional Operating Grant: 2014-2015 program, the selection of Priority Announcements you would like to be considered for during this phase is optional.
• To complete your Application, follow the specific application guidelines and instructions which are fully described in the Operating Grant: Transitional Operating Grant: 2014-2015 "How to Apply" section.
• Reminder to applicants: Please ensure that your application is complete (includes all required signatures) and is submitted on time to CIHR.

Specific Instructions

• To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
• You may request that your application be considered for more than one priority announcement per application, in each Operating Grant competition.

Contact Information

For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

Olivier Jacob-Gravel
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-952-5728
Fax: 613-954-1800
Email: olivier.jacob-gravel@cihr-irsc.gc.ca

If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact:

CIHR ResearchNet Support
Canadian Institutes of Health Research
Telephone: 613-941-9080
Email: support@researchnet-recherchenet.ca

Sponsor Description

Internal Collaborators

Canadian Institutes of Health Research (CIHR)
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened health care system for Canadians. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,700 health researchers and trainees across Canada.

Canadian Blood Services
Canadian Blood Services conducts and supports research in key priority areas that span the translational continuum from “bench to bed side.”

Additional Information

Aboriginal Ways of Knowing and Two-Eyed Seeing (AWT)

• For questions about this initiative and research objectives contact:

  Jacques Dalton
  Associate, Institute Strategic Initiatives
  CIHR – Institute of Aboriginal Peoples’ Health (IAPH)
  Telephone: 613-941-4440
  Fax: 613-954-1800
  Email: jacques.dalton@cihr-irsc.gc.ca

Breast Cancer (Bridge Funding) (COP)

• For questions about this initiative and research objectives contact:

  Anne Morrow
  Associate, Institute Strategic Initiatives
  CIHR – Institute of Cancer Research (ICR)
  Telephone: 613-941-4329
  Fax: 613-954-1800
  Email: anne.morrow@cihr-irsc.gc.ca

Circulatory and Respiratory Health – New Investigators (Bridge Funding) (OCN)

• For questions about this initiative and research objectives contact:

  Jennifer Ralph
  Associate, Institute Strategic Initiatives
  CIHR – Institute of Circulatory and Respiratory Health
  Telephone: 613-941-0086
  Fax: 613-954-1800
  Email: Jennifer.ralph@cihr-irsc.gc.ca

First Nations, Inuit and/or Métis Health (Bridge Funding) (IPH)

• For questions about this initiative and research objectives contact:

  Jacques Dalton
  Associate, Institute Strategic Initiatives
  CIHR – Institute of Aboriginal Peoples’ Health (IAPH)
  Telephone: 613-941-4440
  Fax: 613-954-1800
  Email: jacques.dalton@cihr-irsc.gc.ca

Genetics: Research Priorities (Bridge Funding) (OGB)

• For questions about this initiative and research objectives contact:

  André Fortin
  Associate
  CIHR – Institute of Genetics (IG)
  Telephone: 613-957-6126
  Fax: 613-954-1800
  Email: andre.fortin@cihr-irsc.gc.ca

HIV/AIDS (HOP/HHP/HBF)

• For questions about this initiative and research objectives contact:

  Jane Hutchison
  Associate
  CIHR – HIV/AIDS Research Initiative
  Institute of Infection and Immunity
  Strategic Initiatives Branch
  Telephone: 613-948-9396
  Fax: 613-957-1800
  Email: Jane.Hutchison@cihr-irsc.gc.ca

INMD Start-up Funds (Bridge funding for Clinicians and New Investigators) (INM)

• For questions about this initiative and research objectives contact:

  Kimberly Banks Hart
  Associate, Strategic Initiatives
  CIHR – Institute of Nutrition, Metabolism and Diabetes (INMD)
  Telephone: 613-948-2692
  Fax: 613-954-1800
  Email: Kimberly.Hart@cihr-irsc.gc.ca

Musculoskeletal, Skin and Oral Health: New Investigators (Bridge Funding) (ONM/ONS/ONO)

• For questions about this initiative and research objectives contact:

  Tanya Gallant
  Associate, Strategic Initiatives
  CIHR – Institute of Musculoskeletal Health and Arthritis (IMHA)
  Telephone: 613-954-3469
  Fax: 613-954-1800
  Email: tanya.gallant@cihr-irsc.gc.ca

Neurosciences, Mental Health and Addiction (Bridge Funding) (INO)

• For questions about this initiative and research objectives contact:

  Asimina Saikaley
  Associate
  CIHR – Institute of Neurosciences, Mental Health and Addiction (INMHA)
  Telephone: 613-941-0874
  Fax: 613-954-1800
  Email: asimina.saikaley@cihr-irsc.gc.ca

Reproductive and Child Health Start-up Grants (Bridge funding) (IHD)

• For questions about this initiative and research objectives contact: (Updated: 2015-02-16)

  Sarah De La Rue
  Assistant Director
  CIHR – Institute of Human Development, Child and Youth Health (IHDCYH)
  Telephone: 416-586-4800 ext. 6671
  Fax: 416-586-8546
  Email: sdelarue@mtsinai.on.ca

Transfusion Science (OTS)

• For questions about this initiative and research objectives contact:

  Jennifer Ralph
  Associate, Institute Strategic Initiatives
  CIHR – Institute of Circulatory and Respiratory Health
  Telephone: 613-941-0086
  Fax: 613-954-1800
  Email: Jennifer.ralph@cihr-irsc.gc.ca